Do Tigers and Orioles Injuries Bruise These MLB Contenders?

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Source: hueytaxi / Flickr

In terms of up-and-coming MLB stars, it’s difficult to top the impact Jose Iglesias of the Detroit Tigers and Manny Machado of the Baltimore Orioles have had on the game of baseball. Unfortunately for both contending teams, bad news out of 2014 spring training has put their infielders’ immediate future in doubt, with Iglesias getting terrible news about a shin and Machado potentially missing several games early in the season for the O’s.

Iglesias to miss months

Shortstop Jose Iglesias reported an injury to his shins early in spring training. Originally thought to be a case of shin splints, persistent pain led to further tests that have revealed problems in both legs. According to an ESPN report, Iglesias could be sidelined until the All Star break or later. The report went so far as to say the shortstop could miss the entire 2014 season for the Tigers.

After Detroit shortstop Johnny Peralta was suspended for PED use in 2013, the Tigers front office traded for Iglesias from the Red Sox. The slick-fielding 24-year-old provided an instant defensive upgrade to a team that had been dealing with Peralta at short and Miguel Cabrera at third. Should the injury to Iglesias be as bad as the initial reports, Detroit would have to make a roster move in order to shore up the left side of its infield. Rookie Nick Castellanos will start the season at third base.

Machado to miss Opening Day?

Baltimore third baseman Manny Machado, the 21-year-old phenom who has captivated the league since his 2012 debut, suffered a setback in his rehabilitation following October 2013 knee surgery. Scheduled to be re-evaluated by his doctor, the appointment was cancelled when scar tissue in Machado’s knee prevented him from running smoothly.

More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business